HRES 227 is a non-binding resolution expressing the House of Representatives' support for designating March 18, 2025, as "National Agriculture Day" to honor agriculture's role as a vital U.S. industry. It does not create new laws, allocate funds, or impose requirements on any group. The resolution serves as a symbolic gesture to highlight agriculture's economic impact and contributions to the nation. As a procedural resolution, it has no direct policy effect beyond raising awareness.
HRES 127 is a procedural resolution requesting documents from the executive branch. It directs the President and Treasury Secretary to provide the House of Representatives, within 14 days, any documents related to the Department of Government Efficiency (DOGE) accessing Treasury payment systems or confidential taxpayer data (like tax returns, SSNs, and debt information). The resolution specifically seeks records such as emails, logs, agreements, and screenshots involving DOGE, Elon Musk, or his team. This is not a law but a formal request for transparency regarding access to government systems and taxpayer information.
Financial Integrity and Regulation Management Act or the FIRM Act This bill prohibits the consideration of reputational risk by federal banking agencies when regulating, examining, or supervising a depository institution or credit union. The bill defines reputational risk as the potential for negative publicity or public attention to decrease confidence in the institution, lead to litigation, reduce revenues, or result in other adverse impacts to the institution. Agencies must report on the implementation of this bill.
This bill authorizes $5 million annually (2026-2031) for the CDC to establish a research program focused on cerebral palsy. It directs the CDC to study diagnosis, treatment, prevention factors, health costs, and public health surveillance related to cerebral palsy, including evaluating impacts across different populations. The program aims to address gaps in understanding the condition - where 80% of causes are unknown - and support better care for the estimated 1 million Americans affected. This research funding directly benefits the CDC and researchers, with potential long-term benefits for people with cerebral palsy and their families.
This bill (HR 2199) prevents private health insurance plans from discriminating against patients with end-stage kidney disease (ESRD) who require dialysis. It amends the Social Security Act to prohibit plans from treating dialysis coverage differently than other medical services or applying network restrictions that disproportionately harm ESRD patients. The law clarifies that plans cannot deny or limit benefits for dialysis based on a patient’s diagnosis, while preserving a plan’s right to choose which dialysis providers are in their network. It directly affects ESRD patients and their private health insurance coverage, ensuring dialysis is treated equally with other covered medical services. The bill does not require plans to include specific dialysis providers but stops them from unfairly restricting access to necessary care.
This bill delays two Medicare billing deadlines for ground ambulance services from 2025 to 2028. It amends the Social Security Act to extend the timeline for implementing specific billing rules under Section 1834(l). The change directly affects Medicare ambulance providers by postponing compliance deadlines for billing requirements. No new services or funding are created - only a technical extension of existing timelines.
HR 2205, the NEDD Act, amends existing defense law to expand the Department of Energy's (DOE) authority over drone operations near nuclear facilities. It specifically shifts responsibility from the State Department to the DOE for: (1) exempting DOE from restrictions on purchasing foreign drones, (2) allowing DOE to operate drones near nuclear sites, and (3) managing classified tracking for nuclear facility security. The bill directly affects U.S. nuclear facilities that store, transport, or use special nuclear materials, or research/produce components for nuclear weapons. These changes streamline drone-related security protocols under the DOE’s existing nuclear safety oversight, without creating new restrictions.
The Air America Act of 2025 authorizes one-time payments of $40,000 to individuals who worked for Air America or its affiliated companies for at least five years during 1950-1976, or to their surviving spouses, children, or dependents. Additional payments of $8,000 per full year beyond five years are allowed. The program is capped at $60 million total funding, with claims required within two years of final regulations. Payments are a single lump sum with no ongoing benefits, and the bill explicitly states it does not create new entitlements beyond this one-time award.
HR 2222, the "Lowering Egg Prices Act of 2025," modifies federal egg regulations to allow surplus broiler hatching eggs (used to hatch chicks for meat production) to be sold to egg breakers (facilities that process whole eggs into liquid products). The bill directs the FDA and USDA to create new rules within 180 days permitting these eggs to be stored under conditions compatible with hatching while also being sold for processing into liquid egg products. This change aims to increase the supply of eggs available for processing by making it easier to redirect surplus hatching eggs to egg breakers. The bill directly affects broiler hatcheries, egg breakers, and the broader egg processing industry by altering how certain surplus eggs can be handled and sold.
HR 2202 prohibits federal funds from being used for gender transition procedures or health plans covering them in federal programs like Medicaid and the Affordable Care Act. It does not ban these procedures but restricts federal subsidies, requiring individuals to pay for such coverage using non-federal funds (e.g., out-of-pocket or private insurance not tied to federal programs). The bill defines gender transition procedures broadly to include hormonal treatments and surgeries (e.g., mastectomy, hysterectomy), with exceptions for medically necessary treatments related to disorders of sex development or complications from such procedures. It also clarifies that ACA premium tax credits and cost-sharing reductions cannot apply to plans covering these procedures, though separate non-federal-funded coverage remains an option.
This bill protects pregnancy centers that provide non-abortion services from federal discrimination. It prohibits government entities and recipients of federal funds from forcing these centers to offer, refer for, or promote abortions, or from restricting their life-affirming services like pregnancy testing, counseling, or baby supplies. The law creates a legal path for affected centers to sue if they face retaliation for declining abortion-related activities. It amends federal health law to explicitly shield such organizations from being penalized for their stance.
HR 2197, the "No 340B Savings for Transgender Care Act," prohibits covered entities participating in the federal 340B drug pricing program from using savings from discounted drug purchases to pay for specific transgender healthcare services. The bill amends the Public Health Service Act to ban using 340B savings for sex reassignment surgeries or hormone treatments provided "for the purpose of gender alteration" of transgender individuals. This directly affects hospitals and clinics enrolled in the 340B program, restricting how they allocate funds saved through the program’s discounted drug pricing. The key provision is a targeted restriction on fund usage, not a ban on providing the medical services themselves. The bill focuses on reallocating program savings away from these specific care types.
